click below
click below
Normal Size Small Size show me how
Organ Transplant
Drugs used in Solid Organ Transplant
| Question | Answer |
|---|---|
| Bacterial Infections - organisms | Tuberculosis, Nocardiasis |
| Fungal Infections | Aspergilosis, Blastomycosis, Candidiasis, Cocciodiomycosis, Histoplasmosis, Mucomycosis, PCP |
| Parasitic | Toxoplasmosis |
| Viral | CMV, Epstein-Barrm Herpes SV, Varicella-Zoster virus, Human herpes virus, Parvovirus, Polyomavirus |
| Cyclosporine | Sandimmune, Neoral; Calcineurin Inhibitor |
| Cyclosporine MOA | IL-2 inhibitor |
| Cyclosporine DDIs | metabolized by 3A enzymes; Statins, Sirolimus, Mycophenolate |
| Cyclosporine Drug-Dz interactions | DM, altered bilary flow, live vaccines |
| Cyclosporine ADRs | seizure, hallucinations, insomnia, tremor, paresthesias, gingival hyperplasia, HTN, hepatotoxicity, nephrotoxicity, DM, HLP, hyperuricemia, hyperkalemia, hypomag, hirsuitism, hypertrichosis, acne |
| Cyclosporine monitoring | trough, concentration at two hours |
| Cyclosporine PK | highly protein bound |
| 3A4 inducers | phenytoin, phenobarb, rifampin, CBZ, rifabutin, Nevirapine, Efavirenz, St. John's wort |
| 3A4 inhibitors | nefazodone, delavirdine, indinavir, nelfinavir, ritonavir, saquinavir, azoles, diltiazem, verapamil, nicardipine, macrolides, GFJ |
| Tacrolimus | Prograf; calcineurin inhibitor |
| Tacrolimus MOA | IL-2 inhibitor |
| Tacrolimus DDI | metabolized by 3A4 isoenzymes |
| Tacrolimus Drug-dz interactions | DM, live vaccines |
| Tacrolimus ADRs | seizures, hallucinations, insomnia, tremor, depression, psychosis, anorexia, alopecia, HTN, hepatotoxicity, nephrotoxicity, DM, HLP, Hyperkalemia, hypomag, hypercalcemia, hypophosphatemia, anemia |
| Tacrolimus monitoring | trough (5-20) |
| Tacrolimus PK | highly protein bound |
| Sirolimus | Rapamune; mTOR inhibitor |
| Sirolimus DDI | 3A isoenzymes; cyclosporine |
| Sirolimus Drug-Dz interactions | liver transplantation, lung transplantation, live vaccines |
| Sirolimus ADRs | anorexia, oral ulcers, diarrhea, esophagitis, gastritis, hepatotox, hepatic artery thrombosis, synergistic nephrotoxicity with calcineurin inhibitors, HLP, HTN, hyperkalemia, rash, acnem leukopenia, thrombocytopenia, pancytopoenia, thormbosis, pneumonitis |
| Sirolimus monitoring | trough (5-20) |
| Azathioprine | antiproliferative agent; prodrug to mercaptopurine; interferes with DNA and RNA synthesis |
| Azathioprine DDI | Allopurinol; reduce Azath dose by 65-75% |
| Azathioprine Drug-Dz interactions | renal insufficiency, live vaccines |
| Azathioprine ADRs | retinopathy, N/V, diarrhea, anorexia, pancreatitis, hepatotoxicity, rash, skin cancer, leukopenia, thrombocytopenia, pancytopenia |
| Mycophenolate Mofetil | antiproliferative agent |
| Mycophenolate mofetil DDI | cycloprine, cholestyramine, colestipol, coleveselam, antacids, OC |
| MYco mofetil Drug-Dz interactions | renal impairment, live vaccines |
| Myco Mofetil ADRs | N/V, diarrhea, abdominal pain, leukopenia, thrombocytopenia, anemia, pancytopenia |
| Leflunomide DDI | cholestyramine |
| LEflunomide Drug Dz interactions | renal impairment; live vaccines |
| Leflunomide ADRs | HA, dizziness, neuralgia, neuritis, alopecia, N/V, diarrhea, anorexia, gastroenteritis, esophagitis, colitis, DM, HLP, Hyperthyroidism |
| Orthoclone OKT3 MOA | IgG that binds and facilitates removal of CD3 |
| Orthoclone administration | premed with IV steroids, APAP, and antihistamine one hour prior to first dose; check volume status |
| Orthoclone Drug-Dz interactions | uncompensated CHF/volume overload; risk of pulmonary edema; live vaccine |
| ORthoclone ADRs | dizziness, headache, photophobia, tachycardia, transient lymphophenia, pancytopenia, rigor, tremor, fever, chills, dyspnea, pulmonary edema |
| Orthoclone monitoring | CD3<25 |
| Basilixumab MOA | chimeric monoclonal IgG that binds to CD25 and inhibits IL-2 |
| Basilixumab ADR | severe hypersensitivity |
| Antithymocyte Globulin (equine) | polyclonal Ab; IgG |
| Antithymocyte Admin | premedicate with IV steroids, APAP, and antihistamines |
| Antithymocyte ADRs | infusion related reactions, leukopenia, thrombocytopenia, rash |
| antithymocyte monitoring | CD2<50 |
| antithymocyte globlin (rabbit) DDI | immunoglobulins |
| Azathioprine brand | Imuran |
| Mycophenolate Mofetil Brand | Cellcept |
| Mycophenolate Sodium Brand | Myofortic |
| Leflunomide Brand | Arava |
| Basilixumab Brand | Simulect |
| Daclizumab brand | Zenapax |
| Antithymocyte globulin (equine) brand | Atgam |
| Antithymocyte (rabbit) brand | Thyroglobulin |